Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug for treatment of uterine hypertrophy

A technology for uterine hypertrophy and drugs, applied in the direction of drug combinations, pharmaceutical formulas, plant raw materials, etc., can solve the problems of frequent recurrence, reduce the types and dosage of drugs, increase the burden on the liver and kidney, and relieve the symptoms of endometrium stimulation

Inactive Publication Date: 2013-08-28
汪秀芹
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the above TCM treatment plan ignores that the basic pathological changes of the disease are changes in the smooth muscle cells and blood vessel walls in the myometrium. Clearing heat, cooling blood to stop bleeding and invigorating the spleen, nourishing qi and taking blood only improve the symptom of bleeding, so for It is effective for symptoms such as menorrhagia, early menstruation, and prolonged menstruation
However, the pathological basis of uterine hypertrophy is invalid, resulting in frequent recurrence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1, the weight ratio of raw materials: Chuanchuangshi 10g, nine-layer wind 8g, Aliteng 8g, cat's claw grass 6g, golden buckwheat stems and leaves 6g, dodder 8g, terrazzo vine 6g, angelica 8g, and mountain ginger 3g.

Embodiment 2

[0028] Example 2, the weight ratio of raw materials: Chuanchashi 20g, nine-layer wind 15g, Aliteng 15g, cat's claw grass 10g, golden buckwheat stems and leaves 10g, dodder 15g, terrazzo vine 10g, angelica 15g, and mountain ginger 6g.

Embodiment 3

[0029] Example 3, the weight ratio of raw materials: Chuanchashi 15g, nine-layer wind 10g, Aliteng 10g, cat's claw 8g, golden buckwheat stems and leaves 8g, dodder 10g, terexite vine 8g, angelica 10g, and mountain ginger 5g.

[0030] When in use, decoct the traditional Chinese medicines of the present invention Chuanchashi, Nine Layers, Aliteng, Cat's Claw, Golden Buckwheat stems and leaves, Cuscuta Semen, Trichosanthus, Alpinia Ginger, and Angelica with water, combine the filtrates, and take them in the morning and evening.

[0031] The effective combination and coordination of the above drugs can effectively achieve the purpose of treating uterine hypertrophy with less side effects. The above results are fully proved by the clinical data, and the relevant data are as follows, wherein the drug used in the study is the weight ratio of the bulk drug in Example 3.

[0032] 1 Objects and methods.

[0033] 1.1 Subject.

[0034] 1.1.1 Inclusion criteria: 100 cases of uterine hype...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a drug for treatment of uterine hypertrophy to solve treatment problem of uterine hypertrophy. The drug is characterized by being prepared by processing a plurality of traditional Chinese medicines. The raw material formulation includes by weight: 10-20 parts of maclura cochinchinensis, 8-15 parts of cladostachys amaranthoides, 8-15 parts of alyxia sinensis champ.ex benth., 6-10 parts of root of catclaw buttercup, 6-10 parts of gold buckwheat stem leaf, 8-15 parts of dodder, 6-10 parts of chinese starjasmine stem, 8-15 parts of angelica sinensis, and 3-6 parts of alpinia japonica. Clinical experiments prove that the drug for treatment of uterine hypertrophy has the characteristics of good efficacy and high safety, and is worthy of clinical application and promotion.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating uterine hypertrophy. Background technique [0002] Uterine hypertrophy, also known as diffuse uterine myohypertrophy (DUMH), refers to a disease in which the uterus is uniformly enlarged, the thickness of the muscle layer exceeds 2.5 cm, and it is accompanied by varying degrees of uterine bleeding. The basic pathological changes of uterine hypertrophy are the changes of smooth muscle cells and blood vessel walls in the myometrium. Generally, it can be seen that the uterus is uniformly enlarged, and the muscle layer is 2.5-3.2 cm thick. The cut surface is off-white or pink, with increased hardness, and the fiber bundles are arranged in a braided shape. Vascular bulges in the outer 1 / 3 of the muscular layer, with normal or thickened intima, sometimes accompanied by small leiomyomas (less than 1 cm in diameter) or intimal polyps. [0003] The eti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9062A61P15/00
Inventor 汪秀芹
Owner 汪秀芹
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com